MRNA Sep 2024 120.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 02:43PM EDT
Loading interactive chart…
- Zacks
MRNA Gets Positive CHMP Opinion for Updated COVID-19 Jab
The Committee for Medicinal Products for Human Use recommends marketing authorization for Moderna's updated mRNA COVID-19 jab, Spikevax.
- Investor's Business Daily
Moderna Stock's Three-Year Decline — Is It Time To Sell, Hold Or Buy?
Despite becoming one a household name during the pandemic, Moderna stock has mostly fallen over the past three years amid slow sales.
- Zacks
Novavax Stock Up 9% on FDA Nod for Updated COVID-19 Vaccine
The FDA authorization for NVAX's updated COVID-19 vaccine makes it the only non-mRNA vaccine option in the country.
© 2024 Yahoo. All rights reserved.